Denali Therapeutics Inc.

DNLI · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
147
SEC Filings

Business Summary

Overview and Strategy Our purpose is to bring the power of biotherapeutics to the whole body, including the brain, by discovering, developing, and delivering medicines for people living with serious diseases. Historically, the blood-brain barrier has been a major challenge to the development of medicines for diseases of the central nervous system. While the blood-brain barrier protects the brain and is essential for our survival, it also prevents the delivery of medicines to the brain in suffici...

Next Earnings

Q2 FY2026 — expected 2026-08-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionDNLIdiscussed_in_filing Cybersecurity
topic_mentionDNLIdiscussed_in_filing Trusted Computing
topic_mentionDNLIdiscussed_in_filing Blockchain & Crypto
topic_mentionDNLIdiscussed_in_filing Supply Chain
topic_mentionDNLIdiscussed_in_filing Regulation
topic_mentionDNLIdiscussed_in_filing Automotive
topic_mentionDNLIdiscussed_in_filing Healthcare & Bio
topic_mentionDNLIdiscussed_in_filing Platform & Ecosystem
topic_mentionDNLIdiscussed_in_filing Sovereign & Government
topic_mentionDNLIdiscussed_in_filing Cybersecurity
topic_mentionDNLIdiscussed_in_filing Trusted Computing
topic_mentionDNLIdiscussed_in_filing Blockchain & Crypto
topic_mentionDNLIdiscussed_in_filing Supply Chain
topic_mentionDNLIdiscussed_in_filing Regulation
topic_mentionDNLIdiscussed_in_filing Automotive
topic_mentionDNLIdiscussed_in_filing Healthcare & Bio
topic_mentionDNLIdiscussed_in_filing Platform & Ecosystem
topic_mentionDNLIdiscussed_in_filing Sovereign & Government
topic_mentionDNLIdiscussed_in_filing Cybersecurity
topic_mentionDNLIdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001714899-26-000021EDGAR96K words
2025-02-272024-12-310001714899-25-000066EDGAR
2024-02-282023-12-310001714899-24-000086EDGAR
2023-02-272022-12-310001714899-23-000049EDGAR
2022-02-282021-12-310001714899-22-000058EDGAR
2021-02-262020-12-310001714899-21-000033EDGAR
2020-02-272019-12-310001714899-20-000026EDGAR
2019-03-122018-12-310001714899-19-000015EDGAR
2018-03-192017-12-310001193125-18-086723EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001714899-25-000193EDGAR53K words
2025-08-112025-06-300001714899-25-000170EDGAR
2025-05-062025-03-310001714899-25-000105EDGAR
2024-11-062024-09-300001714899-24-000216EDGAR
2024-08-012024-06-300001714899-24-000169EDGAR
2024-05-072024-03-310001714899-24-000121EDGAR
2023-11-072023-09-300001714899-23-000146EDGAR
2023-08-082023-06-300001714899-23-000120EDGAR
2023-05-082023-03-310001714899-23-000075EDGAR
2022-11-032022-09-300001714899-22-000144EDGAR
2022-08-082022-06-300001714899-22-000123EDGAR
2022-05-052022-03-310001714899-22-000078EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001714899-26-000042EDGAR1K words
2026-03-310001714899-26-000036EDGAR
2026-03-250001714899-26-000030EDGAR
2026-02-260001714899-26-000020EDGAR
2026-01-060001714899-26-000004EDGAR
2025-12-100001628280-25-056363EDGAR
2025-12-040001714899-25-000209EDGAR
2025-12-040001714899-25-000208EDGAR
2025-11-060001714899-25-000192EDGAR
2025-10-140001714899-25-000180EDGAR

147 total filings indexed. 116 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001714899
TickerDNLI
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 64e5b9bcdcf129eab602290dd6c816055beaaf7f7a6b42992198cee2df507acb
parent: 172d0da69d26575506257b720c0a9ded897f068313d69c06ea576bcabd03e251
content hash: e16d02547da321741397adfcf6c5d3c801ba485e1b027fa00b4a3aa7c23742ed
signed: 2026-04-13T04:44:41.302Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf